ProShares Ultra NASDAQ Biotechnology
31 hedge funds and large institutions have $19.8M invested in ProShares Ultra NASDAQ Biotechnology in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 11 closing their positions.
Holders
31
Holders Change
-4
Holders Change %
-11.43%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
4
Reduced
9
Closed
11
Calls
$6.49M
Puts
$9.59M
Net Calls
-$3.1M
Net Calls Change
-$3.22M
Top Buyers
1 |
VKH
1
Virtu KCG Holdings
New York
|
$466K |
2 |
2
Morgan Stanley
New York
|
$621K |
3 |
HF
3
HRT Financial
New York
|
$413K |
4 |
SPC
4
Sigma Planning Corp
Ann Arbor,
Michigan
|
$389K |
5 |
![]()
5
Wolverine Trading
Chicago,
Illinois
|
$274K |